Contemporary clinical trials communications
Abbreviation:
Contemp. Clin. Trials Commun.
Published by:
Elsevier Publishing
Publisher Location: Amsterdam
Journal Website:
http://www.sciencedirect.com/science/journal/24518654
Range of citations in the SafetyLit database:
2016; 3 --
2024; 38
Publication Date Range:
2015 --
Number of articles from this journal included in the SafetyLit database:
38
(Download all articles from this journal in CSV format.)
pISSN = 2451-8654
LCCN = 2016247766 | USNLM = 101671157 | OCLC = 940788490
Find a library that holds this journal: http://worldcat.org/issn/24518654
Journal Language(s):
English
Aims and Scope (from publisher):
Contemporary Clinical Trials Communications is an international peer reviewed open access journal that publishes articles pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from a wide range of disciplines including medicine, life science, pharmaceutical science, biostatistics, epidemiology, computer science, management science, behavioral science, and bioethics.
Contemporary Clinical Trials Communications is unique in that it is outside the confines of disease specifications, and it strives to increase the transparency of medical research and reduce publication bias by publishing scientifically valid original research findings irrespective of their perceived importance, significance or impact. Both randomized and non-randomized trials are within the scope of the Journal. Some common topics include trial design rationale and methods, operational methodologies and challenges, and positive and negative trial results. In addition to original research, the Journal also welcomes other types of communications including, but are not limited to, methodology reviews, perspectives and discussions.
Through timely dissemination of advances in clinical trials, the goal of Contemporary Clinical Trials Communications is to serve as a platform to enhance the communication and collaboration within the global clinical trials community that ultimately advances this field of research for the benefit of patients.
